<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39255548</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2212-1102</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Value in health regional issues</Title><ISOAbbreviation>Value Health Reg Issues</ISOAbbreviation></Journal><ArticleTitle>Main Predictors of Decreasing in Quality of Life in Patients With Post-COVID-19: A Cross-Sectional Study.</ArticleTitle><Pagination><StartPage>101039</StartPage><MedlinePgn>101039</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vhri.2024.101039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2212-1099(24)00072-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to assess physical and psychosomatic manifestations of patients with long COVID and their association with a decreased patient's quality of life (QOL) or different times elapsed since the COVID-19 diagnosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a cross-sectional study. We retrospectively collected the clinical characteristics of adult patients who had tested positive for SARS-CoV-2 and had symptoms at least as early as 4 weeks after COVID-19 in M&#xe9;xico City between April 2020 and February 2021. A total of 179 were included. They answered questions to define chronic symptoms. The Sniffin' Sticks Screening 12 test olfactory evaluation was performed. The diminish of QOL was defined by &#x2265;10 points in the EuroQol visual analog scale between pre- and post-COVID-19, and each dimension of EQ-5D-5L test was evaluated. Chi-square test, Fisher's exact test, Student t test, Wilcoxon rank-sum, and signed-rank test were used as required. A backward stepwise logistic regression analysis determined the factors associated with a decrease in QOL. All analyses were performed using R software version 3.6.3 (R Foundation).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the multivariable analysis, post-COVID-19 pain/discomfort (adjusted odds ratio [aOR] 2.5 [1.66-9.68]; P&#xa0;= .01), anxiety/depression (aOR 13 [1.44-17.23]; P&#xa0;= .03), and persistence of &#x2265;3 symptoms (aOR 2.6 [0.96-7.47]; P&#xa0;= .05) remained statistically significant associated with decreased QOL.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with long COVID-19 have decreased QOL mainly associated with pain/discomfort, anxiety/depression, and &#x2265;3 persistent symptoms. Our findings enhanced the notion of a strong psychosomatic factors involved with long COVID-19. Therefore, these patients might benefit from neuropsychological rehabilitation, although the effect of such interventions should be evaluated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>C&#xe1;zares-Lara</LastName><ForeName>Jonnathan O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Medicina Interna, Fundaci&#xf3;n Grupo M&#xe9;xico, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordinola-Navarro</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmona-Aguilera</LastName><ForeName>Zully</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Hospital General Dr Manuel Gea Gonz&#xe1;lez, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benitez-Altamirano</LastName><ForeName>Gustavo M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Hospital General Dr Manuel Gea Gonz&#xe1;lez, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltran-Ontiveros</LastName><ForeName>Luis D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Hospital General Dr Manuel Gea Gonz&#xe1;lez, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez-Hinojosa</LastName><ForeName>Juan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Hospital General Dr Manuel Gea Gonz&#xe1;lez, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Vejar</LastName><ForeName>Cesar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Hospital General Dr Manuel Gea Gonz&#xe1;lez, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Luis</LastName><ForeName>Bruno A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Infectolog&#xed;a, Hospital General Dr Manuel Gea Gonz&#xe1;lez, M&#xe9;xico City, M&#xe9;xico. Electronic address: bruno_lopez@comunidad.unam.mx.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Value Health Reg Issues</MedlineTA><NlmUniqueID>101592642</NlmUniqueID><ISSNLinking>2212-1099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EQ-5D-5L</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>Author Disclosures Author disclosure forms can be accessed below in the Supplemental Material section.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>18</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39255548</ArticleId><ArticleId IdType="doi">10.1016/j.vhri.2024.101039</ArticleId><ArticleId IdType="pii">S2212-1099(24)00072-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>